Dyne Therapeutics Ownership | Who Owns Dyne Therapeutics?
Dyne Therapeutics Ownership Summary
Dyne Therapeutics is owned by 27.35% institutional investors, 0.69% insiders, and 71.96% retail investors. Blackrock is the largest institutional shareholder, holding 9.11% of DYN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.71% of its assets in Dyne Therapeutics shares.
DYN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Dyne Therapeutics | 27.35% | 0.69% | 71.96% |
| Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 7.39M | 9.11% | $260.69M |
| Ra capital management | 9.71M | 8.84% | $101.61M |
| Atlas venture life science advisors | 8.02M | 7.95% | $188.94M |
| Fmr | 8.00M | 7.93% | $188.41M |
| Blackrock funding, inc. /de | 7.95M | 7.88% | $187.29M |
| Janus henderson group | 7.38M | 7.31% | $173.81M |
| Vanguard group | 6.70M | 6.65% | $157.94M |
| Fcpm iii services b.v. | 5.46M | 5.42% | $128.70M |
| State street | 3.72M | 3.68% | $87.58M |
| Braidwell lp | 3.62M | 3.29% | $37.88M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Atlas venture life science advisors | 8.02M | 23.05% | $188.94M |
| Fcpm iii services b.v. | 5.46M | 21.73% | $128.70M |
| Mpm asset management | 682.38K | 12.92% | $16.08M |
| Tcg crossover management | 2.65M | 6.10% | $62.44M |
| Vivo capital | 1.11M | 2.94% | $26.27M |
| Exome asset management | 258.39K | 2.40% | $2.70M |
| Vr adviser | 2.17M | 1.93% | $22.74M |
| Ra capital management | 9.71M | 1.70% | $101.61M |
| Siren | 1.35M | 1.40% | $31.75M |
| Artal group | 1.52M | 1.36% | $53.53M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | 9.71M | 1.70% | 3.33M |
| Braidwell lp | 3.62M | 1.33% | 2.94M |
| Blackrock | 7.39M | 0.01% | 2.00M |
| Vestal point capital, lp | 1.80M | 1.34% | 1.80M |
| Perceptive advisors | 2.31M | 0.85% | 1.77M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rtw investments, lp | 1.69M | 0.27% | -3.53M |
| Holocene advisors, lp | - | - | -2.35M |
| Adage capital partners gp | - | - | -1.95M |
| Jefferies financial group | - | - | -1.80M |
| Jennison associates | - | - | -1.21M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vestal point capital, lp | 1.80M | 1.34% | 1.80M | $18.83M |
| Frazier life sciences management | 1.44M | 0.69% | 1.44M | $15.10M |
| Norges bank | 950.10K | 0.00% | 950.10K | $22.38M |
| Ikarian capital | 358.84K | 0.46% | 358.84K | $3.75M |
| Nantahala capital management | 345.06K | 0.14% | 345.06K | $3.61M |
Sold Out
| Holder | Change |
|---|---|
| Headlands | -1.00 |
| National bank of canada /fi/ | -1.00 |
| Farther finance advisors | -3.00 |
| Ifp advisors | -3.00 |
| Allworth financial lp | -5.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 25 | -87.86% | 30,059,507 | -73.06% | 27 | 0.22% | 15 | -85.98% | 6 | -90.32% |
| Dec 31, 2024 | 204 | -1.45% | 111,580,268 | -0.38% | 110 | 0.90% | 105 | -10.26% | 62 | 14.81% |
| Sep 30, 2024 | 207 | 5.08% | 111,994,758 | 0.90% | 111 | 0.59% | 117 | -7.14% | 54 | 17.39% |
| Jun 30, 2024 | 197 | 12.57% | 110,993,406 | 16.43% | 136 | 0.99% | 126 | -1.56% | 46 | 58.62% |
| Mar 31, 2024 | 175 | 28.68% | 95,333,552 | 36.34% | 117 | 0.91% | 128 | 85.51% | 29 | -27.50% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 3.08M | 2.71% | - |
| Vanguard US Total Market Shares ETF | 2.65M | 2.35% | 2.40K |
| iShares Russell 2000 ETF | 2.13M | 1.87% | 1.04K |
| Fidelity Growth Compy Commingled Pl O | 1.79M | 1.78% | 348.61K |
| Fidelity Growth Compy Commingled Pl S | 1.84M | 1.62% | - |
| Janus Henderson Global Life Sciences D | 1.76M | 1.55% | -26.83K |
| Janus Henderson Global Life Sciences | 1.76M | 1.55% | 349.99K |
| SPDR® S&P Biotech ETF | 1.66M | 1.46% | 2.15K |
| Janus Henderson Glb Life Scn I2 USD | 1.46M | 1.29% | 32.29K |
| Janus Global Life Science AUSD | 1.43M | 1.26% | 307.37K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 05, 2025 | Cox John | CEO & President | Sell | $54.20K |
| Jun 05, 2025 | Kerr Douglas | Chief Medical Officer | Sell | $17.92K |
| Jun 05, 2025 | Friedl-Naderer Johanna | Chief Commercial Officer | Sell | $1.95K |
| Mar 13, 2025 | Friedl-Naderer Johanna | Chief Commercial Officer | Sell | $1.73K |
| Mar 11, 2025 | Scalzo Richard William | SVP, Head of Finance & Admin. | Sell | $15.28K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | 3 |
| 2025 Q1 | - | 9 |
| 2024 Q4 | - | 24 |
| 2024 Q3 | 2 | 79 |
| 2024 Q2 | - | 26 |
DYN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools